ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

VP3.15, a dual GSK-3β/PDE7 inhibitor, reduces glioblastoma tumor growth though changes in the tumor microenvironment in a PTEN wild-type context.

Maria Castello-Pons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.